News | October 22, 2025
TTK Healthcare reports Q2 FY26 net profit at Rs. 20.38 Cr
TTK Healthcare has reported total income of Rs. 222.58 crore during the period ended September 30, 2025
TTK Healthcare has reported total income of Rs. 222.58 crore during the period ended September 30, 2025
Alkem’s domestic business grew 9.7 per cent versus the Indian pharmaceutical market growth of 8.5 per cent
The company reported revenue from operations at Rs. 6,573.7 crore, up 6 per cent YoY
The operating profit (EBITDA) rose 20.7% to Rs. 156.4 crore
The India Branded Business delivered a 5% YoY growth, reaching Rs. 599 crore in revenue for the quarter
Our specialty chemical businesses have continued to perform strongly, growing double digit YoY
Novartis India has reported total income of Rs. 98.16 crores during the period ended June 30, 2025
Revenue increased 11.4 per cent to Rs. 8,545 crore
For the full year FY25, net profit soared 12x to Rs 345 crore
EBITDA for the period rose by 23.2% to Rs. 3,797 million
Subscribe To Our Newsletter & Stay Updated
